Product Overview: Halotestin Dragon Pharma
Halotestin Dragon Pharma is a fluoxymesterone-based anabolic androgenic steroid compound developed for comprehensive laboratory research applications. This highly potent synthetic derivative demonstrates exceptional androgenic activity in controlled experimental environments, making it valuable for researchers studying androgenic receptor mechanisms and anabolic pathways. Scientists at Stroid UK Shop can examine its unique molecular interactions that distinguish it from other compounds in the fluoxymesterone category. The compound’s distinctive structure allows researchers to investigate specific binding affinities and cellular response mechanisms in muscle and neural tissue studies.
Laboratory Applications
Research applications focus on examining fluoxymesterone’s interaction with androgen receptors and its effects on protein synthesis pathways in cellular models. Laboratory studies investigate its remarkable potency compared to testosterone analogues, with particular interest in its non-aromatising properties that prevent conversion to estrogenic metabolites. Comparative research often examines this compound alongside SARM compounds to understand different receptor selectivity patterns. Scientists analyse its rapid onset kinetics and short half-life characteristics, making it suitable for time-sensitive experimental protocols. Studies also examine its potential neurological effects and aggression-related mechanisms through controlled in-vitro and ex-vivo models. Researchers investigating metabolic pathways can examine how fluoxymesterone affects glycogen synthesis and energy utilisation patterns. The compound’s oral bioavailability makes it particularly valuable for studies examining hepatic metabolism and first-pass effects. Advanced research compares its activity profile with peptide-based modulators to understand different mechanistic approaches to muscle protein regulation.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 9α-Fluoro-11β,17β-dihydroxy-17α-methyl-4-androsten-3-one |
| CAS Number | 76-43-7 |
| Molecular Formula | C₂₀H₂₉FO₃ |
| Molecular Weight | 336.45 g/mol |
| Presentation | Dragon Pharma formulation |
| Storage Temperature | Room temperature, dry environment |
| Stability | Protect from light and moisture |
| Research Grade | Laboratory standard purity |
Research Compliance
Halotestin Dragon Pharma is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. Research institutions must ensure appropriate handling protocols and maintain proper documentation for all experimental procedures. This compound should only be used by qualified laboratory personnel in controlled research environments with adequate safety measures and proper waste disposal protocols in accordance with institutional guidelines.
